-
Annual Review of Virology Sep 2019Autism is a developmental disability that can cause significant social, communication, and behavioral challenges. A report published in 1998, but subsequently retracted... (Review)
Review
Autism is a developmental disability that can cause significant social, communication, and behavioral challenges. A report published in 1998, but subsequently retracted by the journal, suggested that measles, mumps, and rubella (MMR) vaccine causes autism. However, autism is a neurodevelopmental condition that has a strong genetic component with genesis before one year of age, when MMR vaccine is typically administered. Several epidemiologic studies have not found an association between MMR vaccination and autism, including a study that found that MMR vaccine was not associated with an increased risk of autism even among high-risk children whose older siblings had autism. Despite strong evidence of its safety, some parents are still hesitant to accept MMR vaccination of their children. Decreasing acceptance of MMR vaccination has led to outbreaks or resurgence of measles. Health-care providers have a vital role in maintaining confidence in vaccination and preventing suffering, disability, and death from measles and other vaccine-preventable diseases.
Topics: Autistic Disorder; Humans; Measles; Measles-Mumps-Rubella Vaccine; Mumps; Rubella
PubMed: 30986133
DOI: 10.1146/annurev-virology-092818-015515 -
International Journal of Environmental... Mar 2020Mumps is an important childhood infectious disease caused by mumps virus (MuV). We reviewed the epidemiology, pathogenesis, and vaccine development of mumps. Previous... (Review)
Review
Mumps is an important childhood infectious disease caused by mumps virus (MuV). We reviewed the epidemiology, pathogenesis, and vaccine development of mumps. Previous studies were identified using the key words "mumps" and "epidemiology", "pathogenesis" or "vaccine" in MEDLINE, PubMed, Embase, Web of Science, and Google Scholar. We excluded the articles that were not published in the English language, manuscripts without abstracts, and opinion articles from the review. The number of cases caused by MuV decreased steeply after the introduction of the mumps vaccine worldwide. In recent years, a global resurgence of mumps cases in developed countries and cases of aseptic meningitis caused by some mumps vaccine strains have renewed the importance of MuV infection worldwide. The performance of mumps vaccination has become an important issue for controlling mumps infections. Vaccine development and routine vaccination are still effective measures to globally reduce the incidence of mumps infections. During outbreaks, a third of MMR vaccine is recommended for groups of persons determined by public authorities.
Topics: Child; Disease Outbreaks; Humans; Measles-Mumps-Rubella Vaccine; Meningitis, Aseptic; Mumps; Mumps virus
PubMed: 32150969
DOI: 10.3390/ijerph17051686 -
The Journal of Pathology Jan 2015Mumps is caused by the mumps virus (MuV), a member of the Paramyxoviridae family of enveloped, non-segmented, negative-sense RNA viruses. Mumps is characterized by... (Review)
Review
Mumps is caused by the mumps virus (MuV), a member of the Paramyxoviridae family of enveloped, non-segmented, negative-sense RNA viruses. Mumps is characterized by painful inflammatory symptoms, such as parotitis and orchitis. The virus is highly neurotropic, with laboratory evidence of central nervous system (CNS) infection in approximately half of cases. Symptomatic CNS infection occurs less frequently; nonetheless, prior to the introduction of routine vaccination, MuV was a leading cause of aseptic meningitis and viral encephalitis in many developed countries. Despite being one of the oldest recognized diseases, with a worldwide distribution, surprisingly little attention has been given to its study. Cases of aseptic meningitis associated with some vaccine strains and a global resurgence of cases, including in highly vaccinated populations, has renewed interest in the virus, particularly in its pathogenesis and the need for development of clinically relevant models of disease. In this review we summarize the current state of knowledge on the virus, its pathogenesis and its clinical and pathological outcomes.
Topics: Animals; Biopsy; Disease Models, Animal; Genotype; Host-Pathogen Interactions; Humans; Mumps; Mumps Vaccine; Mumps virus; Pathology, Molecular; Predictive Value of Tests; Prognosis; Virology; Virulence
PubMed: 25229387
DOI: 10.1002/path.4445 -
Clinical Microbiology Reviews Mar 2020Mumps is an acute viral infection characterized by inflammation of the parotid and other salivary glands. Persons with mumps are infectious from 2 days before through 5... (Review)
Review
Mumps is an acute viral infection characterized by inflammation of the parotid and other salivary glands. Persons with mumps are infectious from 2 days before through 5 days after parotitis onset, and transmission is through respiratory droplets. Despite the success of mumps vaccination programs in the United States and parts of Europe, a recent increase in outbreaks of mumps virus infections among fully vaccinated populations has been reported. Although the effectiveness of the mumps virus component of the measles-mumps-rubella (MMR) vaccine is suboptimal, a range of contributing factors has led to these outbreaks occurring in high-vaccination-coverage settings, including the intensity of exposure, the possibility of vaccine strain mismatch, delayed implementation of control measures due to the timeliness of reporting, a lack of use of appropriate laboratory tests (such as reverse transcription-PCR), and time since last vaccination. The resurgence of mumps virus infections among previously vaccinated individuals over the past decade has prompted discussions about new strategies to mitigate the risk of future outbreaks. The decision to implement a third dose of the MMR vaccine in response to an outbreak should be considered in discussions with local public health agencies. Traditional public health measures, including the isolation of infectious persons, timely contact tracing, and effective communication and awareness education for the public and medical community, should remain key interventions for outbreak control. Maintaining high mumps vaccination coverage remains key to U.S. and global efforts to reduce disease incidence and rates of complications.
Topics: Disease Outbreaks; Humans; Immunization Programs; Measles-Mumps-Rubella Vaccine; Mumps; Vaccination Coverage
PubMed: 32102901
DOI: 10.1128/CMR.00151-19 -
Journal of the Royal Society of Medicine Nov 2006Although the incidence of mumps orchitis has dramatically declined since the introduction of the childhood vaccination programme, a sharp increase in reported cases of... (Review)
Review
Although the incidence of mumps orchitis has dramatically declined since the introduction of the childhood vaccination programme, a sharp increase in reported cases of both mumps and mumps orchitis has been seen recently in the UK. There are great concerns about mumps outbreaks and the associated risk of infertility; it remains an important clinical condition. Immunization is the best policy to avoid this viral disease.
Topics: Azoospermia; Humans; Male; Mumps; Orchitis
PubMed: 17082302
DOI: 10.1177/014107680609901116 -
Clinical Obstetrics and Gynecology Jun 2012Measles, mumps, and rubella are viral diseases that may adversely affect nonimmune pregnant women and their fetuses/neonates. Prevention of these diseases and their... (Review)
Review
Measles, mumps, and rubella are viral diseases that may adversely affect nonimmune pregnant women and their fetuses/neonates. Prevention of these diseases and their complications can be achieved through measles-mumps-rubella (MMR) vaccination before pregnancy. The vaccine is contraindicated during pregnancy, because it contains live, attenuated viruses that pose a theoretical risk to the fetus. However, accidental receipt of MMR vaccination is not known to cause maternal/fetal complications. MMR immunization is recommended to nonimmune obstetric patients upon completion or termination of pregnancy.
Topics: Contraindications; Female; Health Promotion; Humans; Immunoglobulins; Immunologic Factors; Infectious Disease Transmission, Vertical; Measles; Measles-Mumps-Rubella Vaccine; Mumps; Pregnancy; Pregnancy Complications, Infectious; Rubella; Vulnerable Populations
PubMed: 22510638
DOI: 10.1097/GRF.0b013e31824df256 -
BMC Infectious Diseases Mar 2020Lebanon has experienced several measles and mumps outbreaks in the past 20 years. In this article, a case-based surveillance of both measles and mumps outbreaks in...
BACKGROUND
Lebanon has experienced several measles and mumps outbreaks in the past 20 years. In this article, a case-based surveillance of both measles and mumps outbreaks in Lebanon was carried out in an attempt to outline factors contributing to the failure of elimination plans and to provide potential solutions. The relationship between the outbreaks of both diseases was described and explored.
METHODS
A retrospective descriptive study of confirmed cases of measles and mumps in Lebanon between 2003 and 2018 collected from the Lebanese Ministry of Public Health Epidemiological Surveillance Unit public database was carried out. The information collected was graphically represented taking into consideration dates of reported cases, age groups affected, and vaccination status.
RESULTS
The mean number of measles cases was 150.25 cases/year in the 1-4 years age group, 87 cases/year in individuals aging between 5 and 14, and 63.68 cases/year in those > 14 years old. In the latter group, only 18.05% were unvaccinated. The mean number of mumps cases was 30.4 cases/year in the < 4 year age group and 53.8 cases/year in the 10-19 years age group. During the study period, every spike in measles cases was followed by a similar spike in mumps. 9.66% of measles cases occurred in individuals who received at least 2 doses of the vaccine, 52.26% in the unvaccinated, and 38% in those whose vaccination status was undetermined.
CONCLUSIONS
Measles in Lebanon is a disease of the pediatric population, but adults remain at risk. Outbreaks of mumps followed those of measles and were mainly among adolescents. Presence of a large number of Syrian refugees in the country may further complicate the situation. Vaccination activities need to be intensified.
Topics: Adolescent; Adult; Child; Child, Preschool; Disease Outbreaks; Female; Humans; Infant; Lebanon; Male; Measles; Measles-Mumps-Rubella Vaccine; Morbillivirus; Mumps; Mumps virus; Public Health Surveillance; Refugees; Retrospective Studies; Vaccination; Young Adult
PubMed: 32216754
DOI: 10.1186/s12879-020-04956-1 -
Viruses Jun 2022The resurgence of mumps in vaccinated adult populations has raised concerns about possible waning vaccine immunity or a potential lack of protection to the circulating... (Review)
Review
The resurgence of mumps in vaccinated adult populations has raised concerns about possible waning vaccine immunity or a potential lack of protection to the circulating strain. A number of individual studies have investigated if there are amino acid variations between the circulating wild-type strains and vaccine strains. In these studies, the HN and F mumps surface glycoproteins have been of interest, because of their role in viral infection, and because the HN protein is the target of neutralizing antibodies. Here, we summarize the single nucleotide variants and their potential effect that have been identified between mumps genotypes in the HN and F proteins.
Topics: Antibodies, Neutralizing; Glycoproteins; HN Protein; Humans; Mumps; Mumps virus
PubMed: 35746805
DOI: 10.3390/v14061335 -
International Journal of Environmental... May 2022(1) Background: To explore whether meteorological factors have an impact on the prevalence of mumps, and to make a short−term prediction of the case number of mumps in...
(1) Background: To explore whether meteorological factors have an impact on the prevalence of mumps, and to make a short−term prediction of the case number of mumps in Chongqing. (2) Methods: K−means clustering algorithm was used to divide the monthly mumps cases of each year into the high and low case number clusters, and Student t−test was applied for difference analysis. The cross−correlation function (CCF) was used to evaluate the correlation between the meteorological factors and mumps, and an ARIMAX model was constructed by additionally incorporating meteorological factors as exogenous variables in the ARIMA model, and a short−term prediction was conducted for mumps in Chongqing, evaluated by MAE, RMSE. (3) Results: All the meteorological factors were significantly different (p < 0.05), except for the relative humidity between the high and low case number clusters. The CCF and ARIMAX model showed that monthly precipitation, temperature, relative humidity and wind velocity were associated with mumps, and there were significant lag effects. The ARIMAX model could accurately predict mumps in the short term, and the prediction errors (MAE, RMSE) were lower than those of the ARIMA model. (4) Conclusions: Meteorological factors can affect the occurrence of mumps, and the ARIMAX model can effectively predict the incidence trend of mumps in Chongqing, which can provide an early warning for relevant departments.
Topics: China; Humans; Incidence; Meteorological Concepts; Mumps; Wind
PubMed: 35682208
DOI: 10.3390/ijerph19116625 -
Transplantation and Cellular Therapy May 2021Large outbreaks of measles or rubella occasionally occur around the world, and measles infection can be severe and even fatal in transplant patients. However, limited...
Large outbreaks of measles or rubella occasionally occur around the world, and measles infection can be severe and even fatal in transplant patients. However, limited data are available on immunity to measles, mumps, and rubella (MMR) in adult patients after allogeneic stem cell transplantation (allo-HCT). The aim of this study was to evaluate the immune status against MMR and the effects of vaccination against MMR in adult patients after allo-HCT. A total of 135 adult patients who were alive without relapse and new malignancy at 2 years after allo-HCT were included in this study. We measured IgG antibody to MMR before allo-HCT and annually thereafter. The probabilities of being seropositive to measles, mumps or rubella after allo-HCT were estimated according to the Kaplan-Meier method and compared among groups with the log-rank test. The probability of being seropositive at 2 years after allo-HCT in patients who were seropositive before allo-HCT was 60.6% for measles, 39.7% for mumps, and 52.2% for rubella. History of chronic graft-versus-host disease tended to be a risk factor for the loss of immunity against measles (hazard ratio [HR] 1.69, P = .064) and rubella (HR 1.75, P = .056). To predict the loss of immunity against MMR at 2 years after allo-HCT, we defined the following cutoff values for the IgG index before HCT: 18.2 for measles, 5.3 for mumps, and 21.4 for rubella using a receiver-operating characteristics curve. The lower-IgG groups experienced a significant loss of seropositivity at 2 years (39% versus 82% for measles, P < .001; 13% versus 59% for mumps, P < .001; and 33% versus 90% for rubella, P < .001). After this loss of immunity, 25 patients received a single vaccination against MMR. The seroconversion rates were 64%, 36%, and 72% for measles, mumps, and rubella, respectively. Loss of immunity to MMR commonly occurs in the first several years after transplantation. In the patients who lose the immunity, the seroconversion rate after 1 dose of MMR vaccine given at ≥2 years after transplantation is suboptimal.
Topics: Adult; Antibodies, Viral; Hematopoietic Stem Cell Transplantation; Humans; Measles; Measles-Mumps-Rubella Vaccine; Mumps; Rubella; Vaccination
PubMed: 33775586
DOI: 10.1016/j.jtct.2021.02.027